From: The role of RORα in salivary gland lesions in patients with primary Sjögren’s syndrome
Variable | pSS (n = 34) | NC (n = 12) |
---|---|---|
Age, mean (SEM) | 34.32 (2.225) | 27.25 (7.186) |
Sex (female/male) | 34/0 | 12/0 |
Focus score ≥ 1, n (%) | 29 (85.3) | 0 (0) |
Anti-Ro/SSA, n (%) | 30 (88.24) | 0 (0) |
Anti-La/SSB, n (%) | 19 (55.88) | 0 (0) |
Both Anti-Ro/SSA and Anti-La/SSB, n (%) | 19 (55.88) | 0 (0) |
ANA, n (%) | 32 (94.12) | 0 (0) |
ESR↑, n (%) | 17 (50) | 0 (0) |
IgG > 15.9, n (%) | 24 (70.59) | 0 (0) |
RF > 15.9KU/I, n (%) | 15 (44.12) | 0 (0) |